Check My Meds®

Domain Not Resolving

HSTS

DNSSEC

Content Delivery Network

Font Awesome

nginx

US Privacy User Signal Mechanism

reCAPTCHA

jsDelivr

AJAX Libraries API

Global and North America Chief Compliance Officer HC

Betania Glorio

President

Chris Round

Owner

Derek Main

Eric Dilks

Friedrich Karl

Jack Casey

Jacques Esparza

McGrath Academy Director & Owner

Lauren Dutton

Maureen Gomes

Priscilla Vang

Zhen Su

Head of Global Medical Affairs - Oncology

Jasmine Greenamyer

Vice President, Global Strategic Partnerships

Jeff Way

Director of Structural Biology

Julie Locklear

VP & Head, Health Economics and Outcomes Research

Klaus Urbahns

Site Head, EMD Serono Research and Development Institute, Billerica, MA

Grace You

Chief of Staff

Global Head, Discovery & Development Technologies

Terrie Livingston

Head of Patient Outcomes and Solutions

New England Companies With Less Than $500M in Revenue (Top 10K)

Massachusetts Companies With More Than 10 Employees (Top 10K)

Greater Boston Area Companies With More Than 500 Employees

Massachusetts Companies With Less Than $1B in Revenue (Top 10K)

EMD Serono, Inc. discovers and develops biopharmaceutical products. The company focuses on specialized areas, such as neurodegenerative diseases, fertility, and metabolic endocrinology, as well as oncology. It offers GONAL-f RFF Pen, a pre-filled and ready-to-use multi-dose FSH for the treatment of infertility; Ovidrel PreFilled Syringe, a ready-to-inject liquid infertility treatment; Luveris, a recombinant human luteinizing hormone; and Cetrotide, an gonadotropin releasing hormone antagonist. The company also provides Saizen for growth hormone deficiency in children and adults; Serostim for HIV-associated wasting; Zorbtive for short bowel syndrome; and Rebif for the treatment of relapsing remitting multiple sclerosis (MS). In addition, it offers Fertility LifeLines, an educational service that offers customized information and support to individuals at various stages of the patient journey. The company offers its products through distributors. It has strategic alliances with Newron Pharmaceuticals, SpA; ZymoGenetics, Inc.; Pfizer Inc.; Brigham and Women's Hospital; and CuraScript, Inc. EMD Serono, Inc. was formerly known as Serono, Inc. and changed its name to EMD Serono, Inc. in January 2007. The company is based in Rockland, Massachusetts. EMD Serono, Inc. operates as a subsidiary of Merck Serono S.A.

Rockland

Massachusetts

United States

North America

EMD Serono

CORRECTED: Takeda to cut another 220 jobs in Massachusetts, as Merck KGaA plots office move

EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024

Merck KGaA earmarks €300M for an advanced research center at its HQ site

EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits

FDA grants traditional approval for Merck's Tepmetko

Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in ...

EMD Serono lays out MS therapies' immune-system suppression risks in new campaign

Gilde Healthcare's €140M; EMD Serono to move US HQ to Boston; Arcturus up for $35M milestone

EMD Serono to move HQ to Seaport from the suburbs

A treatment for relapsing forms of multiple sclerosis (MS) that helps reduce the frequency of relapses and slow the progression of disability.

An immunotherapy drug used to treat certain types of cancer, including Merkel cell carcinoma and urothelial carcinoma.

A disease-modifying therapy for relapsing forms of multiple sclerosis (MS) that helps reduce the frequency of relapses and slow the progression of disability.

A treatment for non-small cell lung cancer (NSCLC) with MET exon 14 skipping alterations.

A growth hormone treatment for HIV-associated wasting to help increase lean body mass and body weight.

A fertility treatment that stimulates the ovaries to produce eggs in women undergoing assisted reproductive technologies.

Canada

India

Asia

France

Europe

Nigeria

Africa

HTML5

Lightbox

Symantec Email Security.Cloud

Google Fonts

Akamai Intelligent Platform

Modernizr

GlobalSign

Google Analytics

Google Tag Manager

jQuery

EMD Serono is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, a leading science and technology company in the healthcare, life science, and performance materials sectors.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 2:14 PM	8acc35c2
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 2:14 PM	0f097767
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	022c24b0
crunchbase profile	general	Nov 22, 2024 8:27 AM	aa0915f4
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 8:33 AM	4d38680d
peers	general
news basic	general	Mar 8, 2024 2:14 PM	f8b09683
bundesanzeiger	filings
financials download nd	financials
private financials	financials

EMDS

COM:EMDSERONO

EMD Serono